LNJ
LIVE

Serial Number

79401859

Owner

L&J Bio Co.,Ltd.

Attorney

Yan Song

Filing Date

May 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LNJ Trademark

Serial Number: 79401859 • Registration: 7821382

LNJ is a trademark filed by L&J Bio Co.,Ltd. on May 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

L&J Bio Co.,Ltd. (2 trademarks)

#711-712, A-dong, 128, Beobwon-ro,

Entity Type: 99

Trademark Details

Filing Date

May 2, 2024

Registration Date

June 10, 2025

Published for Opposition

January 7, 2025

Goods & Services

Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier to deliver therapeutic proteins directly to brain tissue, using the dual action therapy platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; none of the foregoing related to the treatment of vaccinia and orthopox viruses

Scientific research in the nature of conducting clinical trials for others in the field of brain and central nervous system diseases; research and development of vaccines and medicines; development of cell therapy products; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research laboratory services for predicting disease; medical research laboratory services in the field of the blood-brain barrier; medical research laboratory services in the field of Alzheimer's disease; none of the foregoing related to the treatment of vaccinia and orthopox viruses

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 29, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 22, 2026 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 13, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 13, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 7, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 7, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 10, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 10, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 10, 2025 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 18, 2025 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Apr 17, 2025 CHPB
ASSIGNED TO PETITION STAFF
Apr 17, 2025 APET
ASSIGNED TO PETITION STAFF
Apr 17, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 13, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 6, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
REFUSAL PROCESSED BY IB
Dec 21, 2024 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 18, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 16, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 19, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2024 REPR